41. de la Rosa M, Rutz S, Dorninger H, Scheffold A (2004) Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34: 2480–2488. 42. Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA (2008) The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol 84: 973–980. 43. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self- tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164. 44. Fehe´rvari Z, Yamaguchi T, Sakaguchi S (2006) The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol 27: 109–111. 45. Wolf M, Schimpl A, Hu¨nig T (2001) Control of T cell hyperactivation in IL-2- deficient mice by CD4(+)CD25(2) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31: 1637–1645. 46. Sgouroudis E, Kornete M, Piccirillo CA (2011) IL-2 production by dendritic cells promotes Foxp3+ regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity 44: 406–414. 47. Guiducci C, Valzasina B, Dislich H, Colombo MP (2005) CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell- produced IL-2. Eur J Immunol 35: 557–567. 48. Zanoni I, Foti M, Ricciardi-Castagnoli P, Granucci F (2005) TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J Immunol 175: 286–292. 49. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, et al. (2005) Syk- dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 510–517. 50. Goodridge HS, Simmons RM, Underhill DM (2007) Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178: 3107–3115. 51. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, et al. (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7: 83–92. 52. Kim HP, Leonard WJ (2002) The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements. EMBO J 21: 3051–3059. 53. Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A (2006) Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann N Y Acad Sci 1079: 198–204. 54. Sojka DK, Hughson A, Sukiennicki TL, Fowell DJ (2005) Early kinetic window of target T cell susceptibility to CD25+ regulatory T cell activity. J Immunol 175: 7274–7280. 55. Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287–296. 56. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882–888. 57. Granucci F, Feau S, Angeli V, Trottein F, Ricciardi-Castagnoli P (2003) Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol 170: 5075–5081. 58. Sauma D, Michea P, Lennon-Dume´nil AM, Fierro A, Morales J, et al. (2004) Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccharide- activated dendritic cells. Scand J Immunol 59: 183–189. 59. Marguti I, Yamamoto GL, da Costa TB, Rizzo LV, de Moraes LV (2009) Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells. Immunology 127: 50–61. Dendritic Cell IL-2 Required for Treg Function 60. Chen Y, Peng Z (2001) A sensitive in situ ELISA for quantitative measurements of cytokines and antibodies secreted by culture lymphocytes. J Immunoassay Immunochem 22: 353–369. 61. Ekerfelt C, Ernerudh J, Jenmalm MC (2002) Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: comparison of ELISPOT, a novel ELISA and real-time RT-PCR. J Immunol Methods 260: 55–67. 62. Brinster C, Shevach EM (2005) Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function. J Immunol 175: 7332–7340. 63. Fehe´rva´ri Z, Sakaguchi S (2004) Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 16: 1769–1780. 64. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235–247. 65. Suffner J, Hochweller K, Ku¨ hnle MC, Li X, Kroczek RA, et al. (2010) Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol 184: 1810–1820. 66. Darrasse-Je`ze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, et al. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206: 1853–1862. 67. Koenen HJ, Fasse E, Joosten I (2003) IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 171: 6431–6441. 68. Piccirillo CA, Thornton AM (2004) Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 25: 374– 380. 69. Ohkura N, Sakaguchi S (2010) Regulatory T cells: roles of T cell receptor for their development and function. Semin Immunopathol 32: 95–106. 70. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 105: 10113–10118. 71. Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, et al. (2008) Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 68: 5972–5978. 72. He´mar A, Subtil A, Lieb M, Morelon E, Hellio R, et al. (1995) Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol 129: 55–64. 73. Yu A, Malek TR (2001) The proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem 276: 381–385. 74. Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, et al. (2011) Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res 51: 153–160. 75. Murphy KM, Heimberger AB, Loh DY (1990) Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250: 1720–1723. 76. Liu CP, Kappler JW, Marrack P (1996) Thymocytes can become mature T cells without passing through the CD4+ CD8+, double-positive stage. J Exp Med 184: 1619–1630. 77. Rigby SM, Rouse T, Field EH (2003) Total lymphoid irradiation nonmyeloa- blative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells. Blood 101: 2024–2032. 78. Yui MA, Herna´ndez-Hoyos G, Rothenberg EV (2001) A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J Immunol 166: 1730–1739. 79. Yui MA, Sharp LL, Havran WL, Rothenberg EV (2004) Preferential activation of an IL-2 regulatory sequence transgene in TCR gamma delta and NKT cells: subset-specific differences in IL-2 regulation. J Immunol 172: 4691–4699. PLOS ONE | www.plosone.org 13 September 2012 | Volume 7 | Issue 9 | e43609